Clinical trialObsTerminated
INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
- Outcome
- Stopped earlyThis is only a chart review. This is not a clinical trial and was inadvertently entered in the system. (Other)
- Phase
- Obs
- Status
- Terminated
- Study type
- Observational
- Start
- September 2006
- Expected end
- January 2007
- Enrollment
- 12 participants
- Sites
- 1
- Primary outcomes
- Time to Death
- Sponsor
- Other
- Results posted
- 2015-03-04
- Last update
- 5 February 2024
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Chart Review of patients with pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.
Detailed description public domain (ClinicalTrials.gov)
Chart Review to describe the clinical outcomes in patients pancreatic cancer treated with combination of irinotecan, oxaliplatin and cetuximab.
Posted results (ClinicalTrials.gov registry) · primary outcome public domain (ClinicalTrials.gov)
Time to Death [From date of treatment until time of death]. Median, Months (Full Range). Treatment Arm (n=11): 7 (3 to 18).